Female sexual disorders: psychiatric aspects.
OBJECTIVE
This manuscript reviews the current information concerning female sexual dysfunction that is relevant to general psychiatric practice.


METHODS
Research identified by the key words sexual dysfunction and prevalence, comorbidity, psychiatric drugs, or pharmacotherapy is reviewed.


RESULTS
Epidemiologic studies indicate that approximately 30% of female subjects between ages 18 and 59 years have sexual complaints of at least 3 months' duration in the past year. A high comorbidity with other psychiatric syndromes exists. Many psychiatric drugs are associated with sexual dysfunction. Drug treatments for female sexual dysfunction are being investigated.


CONCLUSIONS
Knowledge concerning the treatment of female sexual dysfunction is important to the general psychiatric clinician.
Segraves
Robert Taylor
RT
Department of Psychiatry, Case Western Reserve School of Medicine, MetroHealth Medical Center, Cleveland, OH 44109, USA. rsegraves@metrohealth.org
D000928:Antidepressive Agents / Q000008:administration & dosage / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use; D015897:Comorbidity; D003430:Cross-Sectional Studies; D005260:Female; D005783:Gender Identity; D006801:Humans; D012735:Sexual Dysfunction, Physiological / Q000139:chemically induced / Q000175:diagnosis / Q000453:epidemiology / Q000523:psychology* / Q000628:therapy
D000928:Antidepressive Agents; D014150:Antipsychotic Agents